이차고혈압의 진단과 치료

키워드

참고문헌 (41)

1. Tziomalos K, "Secondary hypertension : novel insights", Curr Hypertens Rev, 16, pp.11~ (2020)
2. Williams B, "2018 practice guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension", Blood Press, 27, pp.314~340 (2018)
3. Rimoldi SF, "Secondary arterial hypertension : when, who, and how to screen?", Eur Heart J, 35, pp.1245~1254 (2014)
4. Muiesan ML, "Structural changes in small resistance arteries and left ventricular geometry in patients with primary and secondary hypertension", J Hypertens, 20, pp.1439~1444 (2002)
5. Funder JW, "The management of primary aldosteronism : case detection, diagnosis, and treatment : an Endocrine Society clinical practice guideline", J Clin Endocrinol Metab, 101, pp.1889~1916 (2016)
6. Rossi GP, "A prospective study of the prevalence of primary aldosteronism in 1, 125 hypertensive patients", J Am Coll Cardiol, 48, pp.2293~2300 (2006)
7. Mulatero P, "Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents", J Clin Endocrinol Metab, 89, pp.1045~1050 (2004)
8. Vaidya A, "The expanding spectrum of primary aldosteronism : implications for diagnosis, pathogenesis, and treatment", Endocr Rev, 39, pp.1057~1088 (2018)
9. Byrd JB, "Primary aldosteronism : practical approach to diagnosis and management", Circulation, 138, pp.823~835 (2018)
10. Hundemer GL, "Primary aldosteronism diagnosis and management : a clinical approach", Endocrinol Metab Clin North Am, 48, pp.681~700 (2019)
11. Maiolino G, "Quantitative value of aldosterone-renin ratio for detection of aldosterone-producing adenoma: the aldosterone-renin ratio for primary aldosteronism (AQUARR) study", J Am Heart Assoc, 6, pp.e005574~ (2017)
12. Rossi GP, "Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma", J Hypertens, 25, pp.1433~1442 (2007)
13. Morera J, "Management of endocrine disease : the role of confirmatory tests in the diagnosis of primary aldosteronism", Eur J Endocrinol, 180, pp.R45~R58 (2019)
14. Solar M, "Adrenal venous sampling : where is the aldosterone disappearing to?", Cardiovasc Intervent Radiol, 33, pp.760~765 (2010)
15. Rossitto G, "Subtyping of primary aldosteronism in the AVIS-2 study : assessment of selectivity and lateralization", J Clin Endocrinol Metab, 105, pp.dgz017~ (2020)
16. Reincke M, "Diagnosis and treatment of primary aldosteronism", Lancet Diabetes Endocrinol, 9, pp.876~892 (2021)
17. Williams TA, "Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort", Lancet Diabetes Endocrinol, 5, pp.689~699 (2017)
18. Wu VC, "Long term outcome of aldosteronism after target treatments", Sci Rep, 6, pp.32103~ (2016)
19. Rossi GP, "Practice recommendations for diagnosis and treatment of the most common forms of secondary hypertension", High Blood Press Cardiovasc Prev, 27, pp.547~560 (2020)
20. Herrmann SM, "Current concepts in the treatment of renovascular hypertension", Am J Hypertens, 31, pp.139~149 (2018)
21. Persu A, "Beyond atherosclerosis and fibromuscular dysplasia : rare causes of renovascular hypertension", Hypertension, 78, pp.898~911 (2021)
22. Baumgartner I, "Renovascular hypertension : screening and modern management", Eur Heart J, 32, pp.1590~1598 (2011)
23. Hackam DG, "Angiotensin inhibition in renovascular disease : a population-based cohort study", Am Heart J, 156, pp.549~555 (2008)
24. Losito A, "Survival of patients with renovascular disease and ACE inhibition", Clin Nephrol, 52, pp.339~343 (1999)
25. Prince M, "When and how should we revascularize patients with atherosclerotic renal artery stenosis?", JACC Cardiovasc Interv, 12, pp.505~517 (2019)
26. Neumann HPH, "Pheochromocytoma and paraganglioma", N Engl J Med, 381, pp.552~565 (2019)
27. Lenders JW, "Phaeochromocytoma", Lancet, 366, pp.665~675 (2005)
28. Sbardella E, "Pheochromocytoma : an approach to diagnosis", Best Pract Res Clin Endocrinol Metab, 34, pp.101346~ (2020)
29. Eisenhofer G, "Biochemical diagnosis of pheochromocytoma : how to distinguish true-from false-positive test results", J Clin Endocrinol Metab, 88, pp.2656~2666 (2003)
30. Neary NM, "Drugs and pheochromocytoma--don't be fooled by every elevated metanephrine", N Engl J Med, 364, pp.2268~2270 (2011)
31. Lenders JWM, "Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma : a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension", J Hypertens, 38, pp.1443~1456 (2020)
32. Fishbein L, "Pheochromocytoma", paraganglioma:review of perioperative management of blood pressure and update on genetic mutations associated with pheochromocytoma, 2013, pp.15, 428~434
33. Lacroix A, "Cushing's syndrome", Lancet, 386, pp.913~927 (2015)
34. Lahera Vargas M, "Prevalence, etiology and clinical findings of Cushing's syndrome", Endocrinol Nutr, 56, pp.32~39 (2009)
35. Nieman LK, "The diagnosis of Cushing's syndrome : an Endocrine Society clinical practice guideline", J Clin Endocrinol Metab, 93, pp.1526~1540 (2008)
36. Pecori Giraldi F, "The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states", Clin Endocrinol (Oxf), 66, pp.251~257 (2007)
37. Moro M, "The desmopressin test in the differential diagnosis between Cushing's disease and pseudo-Cushing states", J Clin Endocrinol Metab, 85, pp.3569~3574 (2000)
38. Newell-Price J, "Cushing's syndrome", Lancet, 367, pp.1605~1617 (2006)
39. Broersen LHA, "Effectiveness of medical treatment for Cushing's syndrome : a systematic review and meta-analysis", Pituitary, 21, pp.631~641 (2018)
40. Ferriere A, "Cushing's syndrome : treatment and new therapeutic approaches", Best Pract Res Clin Endocrinol Metab, 34, pp.101381~ (2020)
41. Pedrosa RP, "Obstructive sleep apnea : the most common secondary cause of hypertension associated with resistant hypertension", Hypertension, 58, pp.811~817 (2011)

관련 논문AI추천